The clinical course of patients with idiopathic pulmonary fibrosis

Annals of Internal Medicine

Volumn 142, Issue 12 I, 2005, Pages

  Martinez, Fernando J ^a   Safrin, Sharon ^b   Weycker, Derek ^b   Starko, Karen M ^b   Bradford, Williamson Z ^b   King Jr , Talmadge E ^b   Flaherty, Kevin R ^b   Schwartz, David A ^b   Noble, Paul W ^b   Raghu, Ganesh ^b   Brown, Kevin K ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GAMMA1B INTERFERON; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DETERIORATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IDIOPATHIC DISEASE; LUNG FIBROSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; CAUSE OF DEATH; DYSPNEA; FOLLOW UP; HOSPITALIZATION; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY;

AGED; CAUSE OF DEATH; DOUBLE-BLIND METHOD; DYSPNEA; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY FIBROSIS;

EID: 20544443765     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-12_part_1-200506210-00005     Document Type: Article

References (14)

1. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998;157:1301-15. [PMID: 9563754]
2. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Intersritial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respit Crit Care Med. 2002;165:277-304. [PMID: 11790668]
3. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004;350:125-33. [PMID: 14711911]
4. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000; 161:646-64. [PMID: 10673212]
5. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85:751-8. [PMID: 6723384]
6. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest. 1998;113:619-24. [PMID: 9515834]
7. Panos RJ, Mortenson RL, Niccoli SA, King TE Jr. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med. 1990;88:396-404. [PMID: 2183601]
8. Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest. 1993;103:1808-12. [PMID: 8404104]
9. Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, Yamamoto S. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol. 1997;168:79-83. [PMID: 8976924]
10. Gong MN, Mark EJ. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-2002. A 56-year-old man with rapidly worsening dyspnea. N Engl J Med. 2002;347:2149-57. [PMID: 12501228]
11. Ambrosini V, Cancellieri A, Chilosi M, Zompatori M, Trisolini R, Saragoni L, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J. 2003;22:821-6. [PMID: 14621091]
12. Akira M, Yamamoto S, Hara H, Sakatani M, Ueda E. Serial computed tomographic evaluation in desquamative interstitial pneumonia. Thorax. 1997; 52:333-7. [PMID: 9196515]
13. Schwartz DA, Van Fossen DS, Davis CS, Helmers RA, Dayton CS, Burmeister LF, et al. Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1994;149:444-9. [PMID: 8306043]
14. United Network for Organ Sharing. A guide to calculating the lung allocation score. Accessed at www.unos.org/SharedContentDocuments/A_Guide_to_ Calculating_the_Lung_Allocation_Score.pdf on 25 February 2005.